News Beep

Patient dies in Sarepta gene therapy trial, adding to safety concerns

A 51-year-old man died last month after receiving an experimental gene therapy developed by Sarepta Therapeutics for an…
#NewsBeep #News #Topstories #Biotechnology #drugdevelopment #Headlines #raredisease #STAT+ #TopStories
newsbeep.com/4463/

Uni Göttingen

Three new ERC Proof of Concept grants in Göttingen!

Congratulations to Professors Lutz Ackermann, Timo Betz and Jörg Enderlein and their teams! Initiatives to boost economy and society: uni-goettingen.de/en/3240.html

ERC Grant funding to build on the innovation potential of their research findings #GreenTechnology #DrugDevelopment #BiomedicalImaging #MaterialsScience #Agriculture

Images thanks to Alexey Chizhik #ScienceCommunication

khushbucmi

Viral Clearance Market is driven by increasing demand for biologics purification

The Viral Clearance Market is estimated to be valued at USD 0.99 Bn in 2025 and is expected to reach USD 1.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032.

Viral Clearance Market
coherentmi.com/industry-report

#CoherentMI , #ViralClearance, #Biotech, #Pharma, #DrugDevelopment, #HealthcareInnovation, #ViralSafety, #Bioprocessing, #Therapeutics, #InfectiousDisease,

Innovative Health Initiative

🍿 Missed yesterday's excellent event 'In conversation with ITCC-P4'? 👉 Watch the recording online at europa.eu/!MNBRkD and find out how this project is not just delivering much-needed tools to advance #research and #DrugDevelopment for childhood #cancers, but creating hope for children and their families.
#IHITransformingHealth #HorizonEU #CancerMission

RedRobot

Cambridge-based Maxion Therapeutics raises €68.9 million in Series A funding led by General Catalyst to advance its KnotBody pipeline targeting ion channel and GPCR-driven diseases.Maxion Therapeutics, a Cambridge-based biotech firm, has raised €68.9 million in a Series A funding round led by General Catalyst. #biotech #drugdevelopment #funding #GPCR #ionchannels

redrobot.online/2025/03/maxion